Sabine Mueller Selected Research

Sabine Mueller Research Topics

Disease

70	Neoplasms (Cancer) 05/2024 - 04/2005
52	Glioma (Gliomas) 04/2024 - 04/2005
19	Brain Neoplasms (Brain Tumor) 02/2024 - 09/2015
18	Diffuse Intrinsic Pontine Glioma 02/2024 - 01/2018
6	Glioblastoma (Glioblastoma Multiforme) 04/2024 - 04/2005
5	Stroke (Strokes) 05/2021 - 07/2013
5	Astrocytoma (Pilocytic Astrocytoma) 01/2020 - 04/2005
4	Brain Stem Neoplasms (Brain Stem Tumor) 11/2023 - 02/2018
4	Medulloblastoma 01/2023 - 09/2015
4	Carcinogenesis 01/2021 - 11/2009
4	Neuroblastoma 03/2013 - 11/2009
3	Central Nervous System Neoplasms 01/2023 - 01/2021
3	Vascular System Injuries 01/2022 - 01/2021
3	Cognitive Dysfunction 01/2022 - 01/2021
2	Body Weight (Weight, Body) 01/2022 - 01/2020
2	Neurocytoma 01/2020 - 01/2016
1	Anemia 11/2023
1	Chondrosarcoma 08/2023
1	Lymphoma (Lymphomas) 08/2023
1	Adrenocortical Carcinoma 08/2023
1	COVID-19 03/2023
1	Chronic Disease (Chronic Diseases) 02/2023
1	Craniopharyngioma (Craniopharyngiomas) 01/2023
1	Vomiting 01/2022
1	Dizziness (Lightheadedness) 01/2022
1	Solitary Fibrous Tumors 01/2022
1	Headache (Headaches) 01/2022
1	Hydrocephalus (Hydrocephaly) 01/2022
1	Seizures (Absence Seizure) 01/2022
1	Nausea 01/2022
1	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 01/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Necrosis 12/2019
1	Contact Dermatitis (Eczema, Contact) 05/2019
1	Autistic Disorder (Autism) 01/2019
1	Leukemia 01/2019
1	Measles 01/2019
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2019

Drug/Important Bio-Agent (IBA)

22	dipinacoline glutamateIBA 02/2024 - 03/2014
11	TIC10 compoundIBA 03/2024 - 10/2019
9	Histones (Histone)IBA 08/2023 - 05/2013
5	Biomarkers (Surrogate Marker)IBA 11/2023 - 11/2009
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2016
4	RNA (Ribonucleic Acid)IBA 04/2024 - 10/2019
4	CytokinesIBA 04/2024 - 01/2023
4	AntigensIBA 04/2024 - 01/2018
4	Everolimus FDA Link 11/2023 - 11/2016
4	Phosphotransferases (Kinase)IBA 01/2022 - 10/2015
3	Peptide Hydrolases (Proteases)FDA Link 08/2023 - 12/2021
3	VaccinesIBA 01/2022 - 01/2019
3	Mitogen-Activated Protein KinasesIBA 01/2018 - 01/2017
2	ChemokinesIBA 04/2024 - 11/2023
2	LipidsIBA 04/2024 - 03/2023
2	Messenger RNA (mRNA)IBA 04/2024 - 03/2023
2	tovorafenibIBA 03/2024 - 11/2023
2	ChromatinIBA 08/2023 - 01/2017
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2022 - 11/2016
2	Circulating Tumor DNAIBA 09/2022 - 01/2022
2	adavosertibIBA 01/2022 - 03/2014
2	VemurafenibIBA 05/2020 - 01/2020
2	Radiation-Sensitizing AgentsIBA 01/2018 - 07/2011
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 11/2013 - 09/2013
2	Dihydrotachysterol (AT 10)IBA 07/2013 - 07/2013
2	LuciferasesIBA 12/2012 - 04/2011
2	Vorinostat FDA Link 07/2011 - 04/2011
2	Histone Deacetylase InhibitorsIBA 07/2011 - 04/2011
1	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2024
1	mRNA VaccinesIBA 04/2024
1	TOR Serine-Threonine KinasesIBA 11/2023
1	Ribosomal Protein S6IBA 11/2023
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2023
1	Creatine Kinase (Creatine Phosphokinase)IBA 11/2023
1	Gonadal Steroid Hormones (Sex Hormones)IBA 11/2023
1	PanobinostatIBA 11/2023
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023
1	dinutuximabIBA 01/2023
1	Chimeric Antigen ReceptorsIBA 01/2023
1	MART-1 AntigenIBA 01/2022
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2022
1	Alanine Transaminase (SGPT)IBA 01/2022
1	Apolipoproteins E (ApoE)IBA 01/2022
1	vandetanib (ZD6474)IBA 01/2022
1	ONC206IBA 12/2021
1	romidepsin (FK228)FDA Link 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	quisinostatIBA 01/2021
1	Dasatinib (BMS 354825)FDA Link 10/2020
1	TabletsIBA 01/2020
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 01/2020
1	2,6-dinitrotoluene (DNT)IBA 01/2020
1	Sucrose (Saccharose)IBA 01/2020
1	AllergensIBA 05/2019

Therapy/Procedure

38	Therapeutics 05/2024 - 11/2009
24	Radiotherapy 03/2024 - 07/2013
9	Drug Therapy (Chemotherapy) 01/2023 - 05/2008
6	Immunotherapy 04/2024 - 12/2020
3	Precision Medicine 01/2022 - 10/2019
2	Craniospinal Irradiation 01/2023 - 01/2017
1	Intravenous Administration 03/2023
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2023